COMMUNIQUÉS West-GlobeNewswire

Easy Environmental Solutions Ships First Commercial EasyFEN™ System to Kenya
01/10/2026
September 29 shipment follows successful customer inspection and approximately $1.77 million in customer payments received MANKATO, Minn., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Easy Environmental Solutions, Inc. (OTC: EZES [...]
Health-ISAC® Director of European Operations Elected European Council of ISACs Chair
01/10/2026
Vasileios Mingos to lead cross-sector cyber and physical resilience initiatives across European critical infrastructure networks BRUSSELS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Health Information Sharing and Analysis Center [...]
PolyPid Regains European Commercialization Rights for D-PLEX₁₀₀, Expanding Global Commercialization Opportunities
01/10/2026
PETACH TIKVA, Israel, Oct. 01, 2026 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), an innovative biopharmaceutical company dedicated to improving patient outcomes by elevating treatment [...]
Nox Peptides Announces Expanded Research Focus on BPC-157 and GHK-Cu in Canada
01/10/2026
Toronto, ON, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Nox Peptides has announced an expanded focus on research-use peptide compounds in Canada, highlighting BPC-157 and GHK-Cu as part of its ongoing efforts to support [...]
Legend Biotech Launches Inaugural ELITE Grant Program to Advance the Next Generation of CAR-T Innovation in Multiple Myeloma
01/10/2026
Annual program will award funding to early-career healthcare professionals advancing research, education, and innovation in multiple myeloma BRIDGEWATER, N.J., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Legend Biotech [...]
Legato Frames, the World’s First AI-Based Hearing Glasses, Are Now Available in the U.S.
01/10/2026
Designed for the millions of adults seeking a better alternative to traditional hearing aids, Legato Frames integrate AI-powered sound processing into stylish eyewear built for everyday life. BOSTON, Oct. 01, 2026 ( [...]
Vima Therapeutics to Present New Research at the 2026 International Congress of Parkinson’s Disease and Movement Disorders
01/10/2026
Four presentations highlight significant treatment gaps in isolated dystonia and new research providing mechanistic rationale for targeting muscarinic cholinergic receptors for treating movement disorders BOSTON, Oct. [...]
AONN+ and Manta Cares Partner to Equip Oncology Navigators With AI Tool Purpose-Built for Cancer Patients
01/10/2026
The collaboration provides training, education, and safe AI resources to more than 9,000 oncology nurse and patient navigators nationwide as patients increasingly turn to general purpose AI for cancer information SAN [...]
Carlsmed Appoints Tony Jarc as Chief Product and AI Officer
01/10/2026
CARLSBAD, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced [...]
Chemed To Report Third Quarter 2026 Earnings October 27, Related Conference Call To Be Held On October 28
01/10/2026
CINCINNATI, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the third quarter ended September 30, 2026, on Tuesday, October 27, 2026, following [...]
Lexeo Therapeutics Announces Oral Presentation of LX2006 at the International Congress of Parkinson’s Disease and Movement Disorders 2026 (MDS)
01/10/2026
Oral presentation will highlight previously reported data demonstrating early stabilization or improvement in mFARS scores among LX2006-treated participants compared with propensity-matched control cohort from UNIFAI [...]
Outlook Therapeutics Submits HCPCS Level II Application to CMS for Permanent J-Code for LYTENAVA™ (bevacizumab-vikg)
01/10/2026
Application represents an important step in supporting reimbursement Company remains on track for U.S. commercial launch of LYTENAVA before year-end 2026 ISELIN, N.J., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Outlook [...]
AIM ImmunoTech Spotlights Growing Attention Around Ampligen® Pancreatic Cancer Strategy as DURIPANC Advances Toward Topline Data
01/10/2026
Recent biotech media features focus on Ampligen’s potential to address immune resistance in metastatic pancreatic cancer and the clinical progress of the Phase 2 DURIPANC program OCALA, Fla., Oct. 01, 2026 (GLOBE [...]
Doheny Eye Institute Experts to Share Groundbreaking Insights at the American Academy of Ophthalmology 2026 Annual Meeting
01/10/2026
Doheny-UCLA clinicians will participate in more than 30 educational sessions, scientific papers and posters covering retinal disease, glaucoma, pediatric ophthalmology and other areas of eye care PASADENA, Calif., Oct. [...]
Novonesis completes acquisition of MicroBioGen, strengthening its yeast capabilities
01/10/2026
Novonesis completes acquisition of MicroBioGen, strengthening its yeast capabilities The acquisition adds advanced yeast-breeding expertise with a proven track record in bioethanol and broader potential across [...]
European Medicines Agency Validates PolyPid’s Marketing Authorization Application for D-PLEX₁₀₀
01/10/2026
PolyPid Submitted Marketing Authorization Application to European Medicines Agency for D-PLEX₁₀₀ Last month Validation confirms that the application is complete and EMA initiates formal review of D-PLEX₁₀₀ D-PLEX₁₀₀ NDA [...]
BioCardia Files Revised De Novo Pre-Submission for FDA Approval of Helix™ Catheter
01/10/2026
SUNNYVALE, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- BioCardia ® , Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today [...]
Ernexa Therapeutics CEO Corner Highlights Appointment of Dr. Robert J. Spiegel as Company Sharpens Oncology Focus and Advances ERNA-101 Toward the Clinic
01/10/2026
CEO Discusses How Addition of Accomplished Oncology Drug Developer Strengthens Ernexa Ahead of Clinical Development Following ERNA-101 Data Demonstrating Complete Tumor Clearance and 100% Survival in Combination with [...]
Crohn et Colite Canada investit 1,5 million de dollars dans la recherche sur les MII et les soins futurs
01/10/2026
Quatre équipes de recherche canadiennes étudieront de nouvelles approches pour comprendre, traiter et prévenir la maladie de Crohn et la colite ulcéreuse TORONTO, 01 oct. 2026 (GLOBE NEWSWIRE) -- Le nombre de personnes [...]

Pages